Alkermes Loosens 340B Contract Pharmacy Restrictions in Two States After Appeals Court Ruling - https://lnkd.in/etMKdRz4 An Ireland-based drugmaker recently loosened its 340B contract pharmacy restrictions in Mississippi and Louisiana after a federal appeals court ruled against a drug industry challenge to Mississippi’s contract pharmacy access law [...] #340B #pharmacy #drugpricing
340B Report
Internet News
Washington, DC 10,673 followers
Real-time news and analysis about the 340B Drug Pricing Program
About us
340B Report is the only subscription-based independent news service that provides breaking news coverage and analysis of the federal 340B drug pricing program. We follow all 340B program developments in federal government agencies, Congress, courts, the states, associations, the private sector, academia, and more. If your success rides on staying on top of the 340B program, 340B Report has you covered. SUBSCRIPTIONS Subscribers receive full access to all 340B Report content--articles, breaking news and news alerts, investigative reports, sponsored content--and exclusive 340B Report hosted webinars. You will receive biweekly newsletters directly in your inbox when new articles are published on our website. To learn more about subscriptions visit https://340breport.com/subscribe/. EDITORIAL The 340B Report editorial team welcomes hearing from 340B program stakeholders. ted.slafsky@340breport.com shannon.young@340breport.com william.newton@340breport.com bella.czajkowski@340breport.com The 340B Report editorial team: Long-time healthcare thought leader and journalist, Publisher and CEO Ted Slafsky Associate Editor and Senior Writer Shannon Young Pharmaceutical industry and health policy reporter, Associate Editor and Senior Writer Will Newton National Correspondent Bella Czajkowski. SPONSORSHIP Sponsorship is a great way to reach key decision-makers at 340B hospitals, health systems, community health centers and other HRSA grantees. Visit https://340breport.com/why-sponsor/ to learn more about all the benefits of 340B Report sponsorship or contact Diane Slafsky at diane.slafsky@340breport.com.
- Website
-
https://340breport.com
External link for 340B Report
- Industry
- Internet News
- Company size
- 2-10 employees
- Headquarters
- Washington, DC
- Type
- Privately Held
- Founded
- 2020
- Specialties
- 340B drug pricing program, Pharmacy, Specialty Pharmacy, Contract Pharmacy, 340B Covered Entities, Federally Qualified Health Center, Drug Manufacturers, Drug Pricing, Hospitals, Health Clinic, Disproportionate Share Hospital, HRSA, Ryan White Treatment Center, HIV Treatment Provider, Community Health Center, News Service, Hemophilia Treatment Center, Critical Access Hospital, Primary Care Associations, Biotech Industry, Safety Net Hospitals, Safety Net Clinics, Federal Drug Discount Program, Federal and State Legislation, 340B Program Judicial News, and Regulatory Affairs
Locations
-
Primary
Get directions
Washington, DC, US
Employees at 340B Report
-
Reshma Eggleston
Consultant
-
Diego Ortiz
Enabling businesses to grow by building Outbound Sales Programs, Recruiting, Coaching, Training, and Managing SDR teams
-
Ted Slafsky
Publisher and CEO of 340B Report and Founder and Principal of Wexford Solutions
-
Diane Slafsky
Vice President at 340B Report
Updates
-
Ohio Lawmakers Hear Clashing Testimony on 340B Contract Pharmacy Access Bills - https://lnkd.in/e8SAm_4N Ohio state legislators this week heard conflicting testimony over a pair of bills that would bar drugmakers from restricting 340B contract pharmacy use by federal grantees [...] #340B #pharmacy #drugpricing
-
340B Report Webinar Recap: Experts Discuss HRSA’s 340B Rebate Pilot and Weigh in on its Merits - https://lnkd.in/ecQT_JWc With the Health Resources and Services Administration (HRSA) planning to implement its contentious 340B rebate pilot program at the start of 2026, pharmaceutical supply chain and policy experts offered insights on how 340B stakeholders can prepare for that rollout during Wednesday’s 340B Report, subscriber-only webinar [...] #340B #pharmacy #drugpricing
-
340B Report reposted this
Enjoyed joining the Conversations on Health Care's reporter's roundtable to discuss challenges facing the 340B program:
$44 billion in drugs that help Americans are purchased through a little-known federal discount program called 340B. The program is recognized for successfully helping hospitals, community health centers and others that fund care for low-income patients. But that program is now facing big challenges from drugmakers, and the current government shutdown has brought new uncertainty. Reporters William Newton, 340B Report and David Lim, POLITICO, sit down with our hosts Mark Masselli and Margaret Flinter to explain how what began as a quiet effort to help safety-net providers has grown into a national discussion about drug prices and access to care. Watch the full episode now: chc1.co/798. #governmentshutdown #drugprices #healthpolicy #healthcare #news
-
Navigating the Complexities of Specialty Medication Claims Processing - https://lnkd.in/ep_3if7s SPONSORED CONTENT The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims processing [...] #340B
-
-
340B Industry Leader Spotlight on Sean Hall, Senior 340B Program Director, Visante - https://lnkd.in/e4giRCZN Q: What do you feel is your most significant contribution to the 340B world or to a 340B customer/client? A: In my time at Visante, I am confident that my team and I have been able to contribute significantly in the world of manufacturer restrictions and 340B ESP [...] #340B
-
-
AstraZeneca Challenges Oklahoma’s 340B Contract Pharmacy Access Law - https://lnkd.in/e-3hMYFD A third major pharmaceutical company recently filed a federal lawsuit seeking to block Oklahoma’s 340B contract pharmacy access law [...] #340B #pharmacy #drugpricing
-
State Contract Pharmacy Lawsuit Roundup: Hearing in Oklahoma and New Filing in Vermont - https://lnkd.in/e9TH8RFa Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B Report has launched a roundup to keep [...] #340B #pharmacy #drugpricing
-
Organon Exempts Four New States from 340B Contract Pharmacy Restrictions - https://lnkd.in/eMt_mY23 A New Jersey-based drugmaker this week announced that four additional states will no longer be subject to its 340B contract [...] #340B #pharmacy #drugpricing
-
Report: Trump’s Pharmaceutical Tariffs Will Not Apply to Generic Drugs - https://lnkd.in/eGupxikm President Donald Trump’s planned tariffs on foreign pharmaceutical products will not apply to generic drugs, administration officials reportedly confirmed this week [...] #340B #pharmacy #drugpricing